Aehr Test Systems (NASDAQ:AEHR) Director Howard T. Slayen Acquires 20,000 Shares

Aehr Test Systems (NASDAQ:AEHRGet Free Report) Director Howard T. Slayen purchased 20,000 shares of the company’s stock in a transaction dated Friday, August 2nd. The stock was purchased at an average price of $15.50 per share, with a total value of $310,000.00. Following the completion of the purchase, the director now directly owns 220,714 shares in the company, valued at approximately $3,421,067. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Aehr Test Systems Trading Down 13.1 %

NASDAQ AEHR opened at $14.39 on Monday. Aehr Test Systems has a 12 month low of $9.83 and a 12 month high of $53.06. The firm has a market capitalization of $417.45 million, a PE ratio of 27.67 and a beta of 2.07. The business’s 50-day moving average price is $13.86 and its two-hundred day moving average price is $13.90.

Aehr Test Systems (NASDAQ:AEHRGet Free Report) last released its earnings results on Friday, July 19th. The semiconductor company reported $0.81 earnings per share for the quarter, beating analysts’ consensus estimates of $0.11 by $0.70. The business had revenue of $16.60 million during the quarter. Aehr Test Systems had a net margin of 50.07% and a return on equity of 36.41%. During the same period in the prior year, the company posted $0.21 EPS. As a group, analysts forecast that Aehr Test Systems will post 0.25 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have commented on AEHR. StockNews.com lowered Aehr Test Systems from a “hold” rating to a “sell” rating in a research note on Friday, July 26th. Craig Hallum raised shares of Aehr Test Systems from a “hold” rating to a “buy” rating and boosted their target price for the stock from $12.00 to $25.00 in a report on Wednesday, July 17th.

View Our Latest Stock Report on AEHR

Hedge Funds Weigh In On Aehr Test Systems

Hedge funds and other institutional investors have recently bought and sold shares of the company. Rhumbline Advisers raised its position in shares of Aehr Test Systems by 3.8% in the 2nd quarter. Rhumbline Advisers now owns 39,333 shares of the semiconductor company’s stock worth $439,000 after acquiring an additional 1,438 shares in the last quarter. Versor Investments LP bought a new stake in Aehr Test Systems in the second quarter worth approximately $117,000. nVerses Capital LLC acquired a new position in Aehr Test Systems in the second quarter valued at approximately $25,000. Principal Financial Group Inc. bought a new position in shares of Aehr Test Systems during the 2nd quarter worth approximately $758,000. Finally, Bank of New York Mellon Corp grew its position in shares of Aehr Test Systems by 7.3% during the 2nd quarter. Bank of New York Mellon Corp now owns 101,957 shares of the semiconductor company’s stock worth $1,139,000 after buying an additional 6,896 shares during the period. Institutional investors and hedge funds own 69.69% of the company’s stock.

Aehr Test Systems Company Profile

(Get Free Report)

Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices.

Featured Articles

Insider Buying and Selling by Quarter for Aehr Test Systems (NASDAQ:AEHR)

Receive News & Ratings for Aehr Test Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aehr Test Systems and related companies with MarketBeat.com's FREE daily email newsletter.